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Abstract
HIV-infected children in developing countries are living longer lives as they gain access to antiretroviral
treatment programs. As they grow older, their parents=guardians are faced with the difficult decision of if,
when, and how to inform their child of his=her HIV status. Both negative and positive social, psychological, and
behavioral impacts of disclosure to children have been reported, including improved adherence to medication
regimens. Understanding the disclosure process from the perspective of HIV positive children, therefore, is
critical to developing these interventions. Through children’s experiences we can learn about what works well,
what needs to be strengthened, and what is missing in current disclosure practices. We conducted in-depth
interviews with eight caregiver–child dyads in Kinshasa, Democratic Republic of the Congo. The children were
in a comprehensive HIV pediatric care and treatment program and had already been told their HIV diagnosis.
For the analysis we placed particular emphasis on children’s reports of communication with their caregivers and
health care providers about their illness. Patterns emerged of limited communication between children and their
caregivers as well as their providers, before, during, and after disclosure. From the perspective of children in this
study, disclosure was largely a discrete event rather than a process. Sociocultural contexts surrounding
HIV=AIDS, as well as health status, variations in parent–child communication and the relationships between
health providers and children under their care, should inform psychosocial interventions delivered alongside
treatment programs.
Introduction
With the increasing availability of antiretroviraltreatment in sub-Saharan Africa, more HIV-infected
children will survive into adolescence and adulthood. How-
ever, despite evidence from industrialized countries indicat-
ing that informing children can have positive psychosocial
and clinical outcomes,1,2 limited research has been conducted
on what, when, and how HIV-infected children are told about
their illness.
The literature on disclosure of HIV status to infected chil-
dren conceptualizes disclosure two ways. The first envisions
disclosure as a one-time event, when information about
the diagnosis of HIV or AIDS is provided to the child.3–6
The second conceptualization sees disclosure as a process.
One perspective of the process is from caregivers=parents
providing information and the steps they undertake.7–10
A second perspective is from the child receiving the infor-
mation.11–17
Prevalence of disclosure to infected children varies. A re-
cent review of pediatric disclosure literature from the United
States, Canada, and Europe reported that 10–75% of HIV-
infected children had been informed of their HIV status.18 The
review noted most studies provided limited details on when
full disclosure occurred, what was discussed and how often.
Table 1 summarizes disclosure prevalence from four studies
in developing countries, which reported 29–62% disclosure.
Table 2 summarizes factors influencing disclosure. Reasons
for disclosure most frequently reported in the United States,
Canada, and Europe were child’s age and cognitive devel-
opment.4,7,8,13 Similar factors were reported by studies in
developing countries.
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Both negative and positive social and psychological im-
pacts of disclosure to children have been reported. Children
with other illnesses, such as cancer, have been found to be at
risk of emotional and behavioral difficulties resulting from
disclosure.19–21 Others have found that children benefit from
an open discussion of their illness and that nondisclosure does
not necessarily protect them from psychological distress.22–24
HIV-infected children in industrialized countries fared well
after disclosure, and better than children who were unaware
of their HIV infection.1,19,25,26
While studies have looked at correlates of disclosure, few
have investigated the process of disclosure to HIV-infected
children specifically, particularly in developing countries.
This study was, therefore, exploratory and focused on the
experiences of infected children in a comprehensive HIV pe-
diatric care and treatment program in Kinshasa, the Demo-
cratic Republic of the Congo (DRC). The study’s aim was to
explore the events before, during, and after disclosure to
generate a narrative of Congolese children’s experiences with
being told their HIV status. Findings could be used to inform
future interventions to support families and pediatric care
providers through the process of disclosing HIV status to in-
fected children in the DRC and other similar settings.
This study was embedded within a comprehensive, family-
centered HIV care and treatment program in Kinshasa, DRC.
Funded by the U.S. Centers for Disease Control and Preven-
tion (CDC), the program had enrolled over 800 children and
200 of their first-line relatives as of July 2008, providing them
with clinical and psychosocial care, including antiretroviral
treatment when appropriate.
Methods
In-depth interviews were conducted with children, ages
8–17 years, who had undergone full HIV disclosure, as well as
with their primary caregivers. The research was approved by
the Institutional Review Boards at the University of North
Carolina at Chapel Hill in the United States and the Kinshasa
School of Public Health in the DRC. Informed consent,
parental consent, and informed assent were obtained as ap-
propriate.
Recruitment
Program staff contacted potentially eligible participants
based on their existing knowledge of the enrolled children;
primary caregivers were informed of the study and invited to
come with the child to the hospital at a time most convenient
to them. In addition, staff screened all caregivers of children,
ages 8–17 years, when they presented for a regularly sched-
uled visit to identify those who might have disclosed to their
HIV-infected child without informing the clinical team. Those
meeting eligibility criteria were told of the study; if they
agreed to participate, an appointment was made for them to
return for the interview.
Eligibility was reassessed by program staff on the day of
the interview, before obtaining informed consent. A child was
considered to have been fully informed of his or her status if
the terms HIV, AIDS, or any local term specifically associated
with HIV=AIDS had been used in a discussion with the child
about the child’s health. If the child was unable or unwilling to
state that she=he had HIV, AIDS, or other local terms used for
Table 1. Prevalence of Disclosure among HIV-Infected Children in Developing Countries
Authors Country Disclosure details
Bikaako-Kajura et al., 2006 Uganda 29% of sample of 42 children 5–17 years had been fully
disclosed their status, 38% had been given partial information
Menon et al., 2007 Zambia 37.8% of 127 HIV-infected adolescents, ages 11–15 years,
had been told of their HIV infection.
Oberdorfer et al., 2006 Thailand 30.1% of 103 caregivers reported having disclosed to
children 3–13 years old; however, only 53% had actually mentioned
HIV and=or AIDS to their child (16% of the total sample)
Butterworth, 2007 Thailand Disclosure is greater in older age groups: 0% of 6–9 year olds, 18.8%
of 10–13 year olds, and 62.5% of 14–17 year olds had been disclosed (n¼ 87).
Table 2. Factors Influencing Disclosure to HIV-Infected Children, from Existing Literature
Industrialized Countries
Child’s age and cognitive development (DeMatteo et al., 2002; Funck-Brentano et al., 1997; Gerson et al., 2001; Ledlie, 1999)
Child’s deteriorating health status (Funck-Brentano et al., 1997; Gerson et al., 2001; Grubman et al., 1995)
Questioning by the child (Lester et al., 2002; Wiener et al., 1996)
Need to maintain family trust (DeMatteo et al., 2002; Nehring et al., 2000)
Child’s right to know (Lester et al., 2002b; Nehring et al., 2000)
Developing Countries
Starting treatment or problems adhering to treatment (Azondekon et al., 2005; Nannyonga-Musoke et al., 2007; Oberdorfer
et al., 2006)
Level of cognitive development and the age preceding the onset of puberty (Myer et al., 2006).
Reasons for NOT disclosing: young age, the desire to protect the child from psychological harm and to protect the child
and=or family from social stigma (Ayres et al., 2006; Kouyoumdjian et al., 2005; Oberdorfer et al., 2007; Oberdorfer et al.,
2006)
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HIV=AIDS during eligibility screening, she=he was not
interviewed to avoid causing emotional distress to the child.
In the one occasion this occurred, only the caregiver was
interviewed.
If both the caregiver and the child consented, the two in-
terviews were conducted separately and simultaneously, each
by a different interviewer. If the caregiver preferred to be
present during the child’s interview, the adult interview was
conducted first, in the absence of the child, followed by the
child’s interview, which was conducted by the same inter-
viewer.
Data collection and analysis
The adult interviews began with structured questions on
individual (demographics, time since diagnosis, educational
levels of both caregiver and child) and family characteristics
(relationship of caregiver to child, marital status, child’s or-
phan status). The remaining questions were open-ended in
order to best capture disclosure experiences. These questions
explored preparation activities, anticipated reactions of child,
the moment of disclosure, and what had taken place since the
initial disclosure moment. The child’s interview did not in-
clude structured questions; instead, it began with an explo-
ration of the child’s understanding of his=her health prior to
disclosure, moved into a description of the disclosure event
and his=her reaction, and then into events since the full dis-
closure moment. The child’s opinion on disclosure and
his=her understanding of HIV before and after disclosure
were also explored. Questions were adapted from interview
guides used in previous studies7,27,28; additional questions
were developed from themes emerging from the analysis of
formative research completed the previous year.29 Interviews
were semistructured, with opened ended questions and lists
of probes provided to interviewers.
Two local interviewers trained in research methods and
issues surrounding disclosure conducted the interviews,
which were audiotaped with participant permission. One
conducted the interviews with adults, and the other con-
ducted interviews with children, in order to maintain con-
sistency in technique across interviews. Participants had a
choice of being interviewed in either French or Lingala, the
local language; one child and one caregiver were interviewed
in French. Adult interviews lasted approximately 90 min,
while child interviews lasted between 60–90 min each. All
interviews were transcribed directly into French by the in-
terviewer who conducted the interview, and then verified by
a second interviewer, both for completion of the transcript as
well as accuracy of the translation from Lingala to French.
Analysis was conducted in French.
Data were analyzed using qualitative content analysis to
identify themes and patterns related to research questions.30
Deductive and inductive codes were developed and applied
to the data using Atlas.ti v. 5.2. To ensure intercoder reli-
ability, selected transcripts were independently coded by
two analysts, who then compared codes and resolved
discrepancies where necessary. Data display and reduction
tables were developed with feedback from the research team.
Results
Of the 259 children screened, only 8 (3%) were identified as
having been told their HIV status. One child did not state she
had HIV during the screening process and was not inter-
viewed; only her caregiver was interviewed. In the case of
another child, both biological parents requested to be inter-
viewed. In total, we completed in-depth interviews with 8
families, represented by 7 children and 9 of their caregivers.
All children interviewed were on antiretroviral regimens at
the time of the interview. Table 3 provides basic demographic
information about the families interviewed.
The findings are presented linearly to create a narrative of
the events before, during and after disclosure. Although
findings emerged from responses from both caregivers and
their children, particular emphasis was given to the views
expressed by youth. To provide a detailed picture of the
children’s experiences within families and with the health care
system, special attention was paid to the communication
within caregiver–child dyads as well as between health pro-
viders and the children.
Before full disclosure
Before being told their HIV status, children knew they were
sick and suffering from multiple symptoms but believed they
would be cured one day. They described receiving either no
information about their health or information that was in-
complete or misleading. One mother reported telling her child
that she had an inoperable spleen condition, which was mis-
leading. Another child thought he had tuberculosis, based on
symptoms and a prior diagnosis.
Before full disclosure, children rarely communicated di-
rectly with their health care providers about their illness. Only
1 of 7 children reported a direct conversation with a health
care provider about her illness before being told her HIV
status. The other children either made no mention of com-
municating with health care providers or noted providers
only initiated conversations with their parents. Two children
expressed concerns about their illness directly to their pro-
viders; they received general information on chronic illness,
recommended actions to avoid contaminating others, or were
told not to worry.
Interviewer: And the doctors from those hospitals, what did
they tell you?
Participant: They also told me nothing. They would always say
that it was malaria. (17-year-old female)
Before full disclosure, communication between children
and caregivers revolved around children’s questions about
their health. Only one child reported having no conversation
about his illness before he was disclosed his HIV status. All
other children described posing questions to their parents,
especially mothers, about what sickness they had, why they
were constantly ill, or why they had to continually take
medications.
Parents’ responses were described by children as none,
nonspecific, or advice to stop worrying and place their faith in
God. The nondirectness of such responses from parents had
an emotional effect on children:
There are times when I cried, why only me and not my
sisters . . . when I said that, only me, sometimes they would say
to me . . . it’s nothing, it’s just the way it is . . . it will change.
(15-year-old female)
. . . I would worry inside me, mother suffers, I suffer also, but
who will help whom? . . . . Mother told me nothing. Perhaps
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it is an illness that disturbs her and bothers me as well.
(15-year-old female)
Children’s reports on questions they posed to parents
about their illness before full disclosure were largely corrob-
orated by parents=caregivers. The parents of two adolescent
girls mentioned questions about why they were not devel-
oping physically like their peers. The few parents who said
their child had never asked them questions described initiat-
ing conversations on the importance of taking medication.
Parents viewed these health-related conversations as an im-
petus for informing their children of their HIV status.
Parents thought about informing their children before
telling them about their HIV diagnosis, but rarely prepared
the child to receive the information. All parents interviewed
anticipated that their children would react negatively to
learning their HIV status. They thought their child would be
worried, sad, or cry. A few thought their child could possibly
try to harm herself after disclosure. Nearly half of parents
reported not preparing the child at all for full disclosure; of
those, two disclosed during moments of frustration with their
children’s adherence to treatment. Among parents who had
prepared their child for full disclosure, they did so on the day
of full disclosure, often in the moments immediately preced-
ing the event. Preparation activities included preparing
favorite foods, offering gifts, and making sure the child felt
loved.
Medications featured strongly in parents’ decisions to
prepare their children for full disclosure, either because chil-
dren were increasingly recalcitrant in taking them, or because
they were starting antiretroviral regimens. Parents also cited
the need for children to take precautionary measures to pre-
vent infection of siblings and others.
In any case, so that he take his medicines. He would resent and
question taking his medicine every day, ‘‘Why this, mother?’’
He would also ask ‘‘Until when do I have to take it?’’ Another
reason [to tell him] is that I was scared for his younger sibling.
(38-year-old biological mother of an 8-year-old male)
Three parents specifically mentioned the increasing age of
their daughters and concern about infecting others through
sexual transmission.
. . . I told myself, no, I just have to tell her because she will . . . as
she is a young girl maybe men will chase after her, so it I really
had to tell her the illness she has. (48-year-old biological
mother of a 17-year-old female)
From children’s perspectives, only one said she was well-
prepared by her mother, who spoke to her of her health,
showed her love and affection, and provided her with advice
to seek strength in God. The mother explained that she strove
to ensure that her child would not feel she was being treated
differently from the rest of her siblings, and to explain that
people often misunderstand what they do not experience
themselves. This child also reported being prepared in the
weeks before by health care providers, who had her research
information about various chronic illnesses, including HIV.
The moment of full disclosure
Table 4 summarizes characteristics of the moment of full
disclosure of the child’s HIV status, as reported by adults and
Table 3. Basic Demographic and Clinical Characteristics of Families Interviewed
Family A B C D E F G H
Adults
Age 34 38, 45 30 46 41 53 44 48
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children. In all but one case, parents were aware of their
child’s HIV diagnosis for several months, if not several years,
before the child was informed. At the moment of full disclo-
sure, two children were on antiretroviral regimens and two
were about to start. There were discrepancies between chil-
dren’s and adults’ reports about who did the informing,
where, and who else was present.
The moment of disclosing HIV status to children included
minimal information about the illness itself. Two of the three
youth informed by health providers mentioned some infor-
mation provided to them in addition to being told of their
status—one over several visits, the other through a video
screening in a support group. The information provided
clinical context to the illness by discussing chronic illnesses or
how medications can keep a person healthy. One youth told
her HIV status by a health provider said that she was given
information about how HIV works and how the drugs work
to keep the infection at bay. A few noted that medications
featured in the disclosure conversation, whether as a starting
point for discussion or as advice on staying healthy. Others
specifically noted they were told not to worry as it will cause
them to become sicker or die; this message featured in con-
versations with caregivers as well as with providers. Several
youth who had been told by caregivers reported discussing
the source of infection with a parent; none of the youth who
had been informed by providers mentioned discussions about
HIV acquisition during the conversations.
Interviewer: What else did mother do or say?
Participant: She said that I should not worry. If not I will
die . . . (11-year-old female)
I was told to properly follow the treatment so that I may be
cured. (14-year-old male)
They explained to me how that (the drug) works in the body
and what it will do when I will stop. They explained how it’s
given . . . with the ARV [antiretroviral medications], one will
lead it [to a cure] . . . it [the cure] is not yet there by regular
means. (15-year-old female)
Medications feature prominently in disclosure discussions
reported by parents. All conversations touched upon medi-
cations—as the entry point for full disclosure, as part of the
description of the illness, or as part of the advice given to the
child on how to act. A few parents stated they gave some
description of how HIV=AIDS works in the body as part of
the rationale for having to take medications. Several talked
about avoiding contaminating others by not sharing sharp
objects.
Some of the HIV-positive parents revealed their own status
whilst informing their child of their own HIV status, to
comfort and reduce the possible distress of the child. In the
one case the mother did not inform the child of her status, but
the father reports telling the child in a subsequent conversa-
tion. The one caregiver who did not share her own HIV status
with the child had informed her child of her HIV status in a
moment of anger. Only one child mentioned learning of her
parent’s HIV status at the same time as she learned about her
own status.
Upon learning their HIV status, children felt sadness and
worry, but also relief. Children described feeling heartbroken
or sad immediately upon learning their HIV status. Those
who offered reasons for these emotions specifically men-
tioned the stigmatizing nature of HIV.
That hurt me a lot. Because this illness, it is for the debauchers,
but me, at this age, I cannot have this illness. (11-year-old
female)
Table 4. Basic Characteristics of Moment of Full Disclosure
Family A B C D E F G H
Child age
at disclosure




5 months 3 months 9 months 6 months 14 years 1 year Same day *1 year
Time since
disclosure
6 months 4 months 3–4 months 1.5 years 1 year 1.5–2 years 5–6 months 7 months
Location of
disclosure
Home P: home Home P: home Home Home Hospital Home
Y: hospital Y: hospital
Who disclosed Mother P: mother Mother P: mother Mother Father Nurse=
counselor
Mother
Y: doctor Y: doctor
Who else Present No one P: no one Aunt P: alone No one No one P: no one P: no one









Yes Yes No Yes Yes No Noa Yes
aDisclosure done at the moment of diagnosis.
Note 1: information from both interviews is included in the table where discrepancies exist between the parent and the child reports of the
disclosure moment.
Note 2: All children were reportedly in good health at the time of disclosure.
P, parent report; Y, child report.
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At the same time, children described feeling relief in
learning what was causing their illness so that they could now
take care of themselves.
I felt . . . well, I did not feel uneasy, I was well . . . really, as for
worries, I did not have any, I did not have any worries . . . I was
happy that they told me this news; I love my mother a lot up to
today because she told me the truth beforehand. (15-year-old
female)
Other initial reactions included feeling nothing because
the child did not believe the diagnosis or feeling reassured
after a family member explained that it was a disease like any
other.
To probe further on children’s reactions to learning their
HIV status, interviewers presented a list of emotions ex-
pressed by other infected children. When asked whether they
too had felt that way and why, most said they were worried
upon first hearing their diagnosis, citing either fears that they
would become sicker or disbelief that they could have this
illness. Many felt sad upon learning their HIV status, because
of their young age and the stigma associated with the illness.
At the same time, most children reported being relieved to
have a name to put to their suffering.
There was like a hard ball in me, I was uneasy . . . I only wanted
to know my illness . . . as I heard the name of my illness, I was
relieved: I found my inner peace. . . . (15-year-old female)
Those who felt calm at the moment of the full disclosure
explained that learning their HIV status brought them peace
after not knowing from what they were suffering.
Well, when I left [the hospital], I implored God, told him to
give me peace because I did not know . . . I risk dying like that
[she says it with an affirmative head gesture]. I felt a calm fill
my heart, I began to play. (15-year-old female)
In contrast, parents recounted quite different reactions of
their child to being told their HIV status. Most parents de-
scribed their child as having no reaction or not being sur-
prised, attributing it either to the effective way the diagnosis
had been communicated or that the child did not understand
what had been told. Parents described their child’s surprise or
weeping upon being told their HIV status, explaining that the
child did not expect it or did not understand how she=he
could have gotten it. A few parents also reported their child
asking questions.
After full disclosure
After full disclosure, children received HIV-related advice
and instruction from their caregivers, but were not engaged in
discussions about their health. Children distinguished re-
ceiving HIV-related information from their parents from be-
ing engaged by their parents in discussions about their HIV
status. Youth reported receiving advice from their caregivers
ranging from medication adherence and appointment re-
minders, to avoid worrying, how to protect siblings from in-
fection, and spiritual guidance.
He told me to take my medicines correctly. (15-year-old male,
about conversation with his biological father)
She only said to have hope, even if it is what, even if it is
AIDS, God, he, atoned for this illness on the cross, he will heal
me. (15-year-old female, about conversation with her biologi-
cal mother)
Nevertheless, all but one child interviewed said they had
had no discussion with their parents about their HIV status.
For this one child, the discussion was with her mother and not
her father.
This pattern of one-way instruction from parents, rather
than two-way parent–child discussion, was also described by
parents, who reported giving the same kinds of advice as
reported by their children following the moment of full dis-
closure. Those who noted that they had not discussed their
children’s health status since disclosure acknowledged feeling
uncomfortable talking about HIV, preferring to only give
advice.
I do not know if she is aware that I am not happy with this kind
of chatter. (Biological mother of 17-year-old female)
One notable difference in parent–child communication af-
ter disclosure was reported by parents who are HIV-positive,
who incorporated their own HIV status into their advice on
the importance of taking medications.
Parents were unaware of children’s questions and concerns
following full disclosure. Most children reported having at
least one question or concern following disclosure, wanting to
know more about the source of their infection, confirming the
diagnosis, getting better or cured, and AIDS being fatal. Most
children did not voice their questions or concerns to anyone,
but those who did said they had turned to their parents—in
particular, their mothers. In two instances, mothers worked in
tandem with health professionals to address their child’s
concerns. Only one child spoke to a health provider rather
than to a parent. Children reported their questions were either
ignored or deflected with advice to stop worrying or else they
would become sicker.
It was not surprising, therefore, that most parents de-
scribed their child as not having any questions or concerns
following the moment of full disclosure. One mother ac-
knowledged that her child may refrain from asking ques-
tions, knowing that the mother is uncomfortable discussing
HIV. Parents who reported children expressing concerns
cited questions about: whether a cure would be found; tak-
ing drugs for life; how a child could be infected; and being
able to finish school. Following full disclosure, conversations
between children and health providers remained clinically
focused. All but one child interviewed described conversa-
tions with health providers following full disclosure of their
HIV status. Conversations focused largely on instructions to
take medications on time to avoid becoming ill again; ways
of protecting others from infection; and the importance of
not worrying.
They give me advice for me to not worry, like other children
who are worried . . . you start to isolate yourself, to stay alone
saying that AIDS is there to kill me, the way I am, I will die,
I am going to die—me, I do not act that way. (15-year-old
female)
Children also reported being asked questions about their
physical well-being, any symptoms, and whether drugs were
being taken as prescribed. Two children described conversa-
tions in their presence between health providers and their
parents; one to persuade the child to adhere to the treatment
plan and the other on AIDS being bad. This latter topic was
reported by the youngest child interviewed, who repeatedly
raised this message throughout his interview.
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Interviewer: What did the doctor tell you?
Participant: He said that it is bad.
Interviewer: What is bad?
Participant: AIDS.
Interviewer: What else did he say?
Participant: Just that.
Interviewer: Who did the doctor say that to?
Interviewer: To father. (8-year-old male, recounting words
of health care provider)
In summary, after full disclosure, children’s communica-
tions with health providers focused on clinical care.
Children felt that knowing their HIV status was important
and necessary. Despite the negative emotions reported by
children at the time of disclosure, they did not state any
negative consequences of knowing their HIV status. Overall,
the children interviewed named at least one positive aspect of
knowing their diagnosis. The benefits cited included: know-
ing themselves or knowing their bodies; no longer worrying
to avoid becoming sicker; and being able to protect others
from infection.
Participant: So . . . I no longer worry that I am sick. I take the
drugs. Sometimes I even forget.
Interviewer: What do you forget?
Participant : I forget that I am sick, that I take drugs. It comes
back to me only at the time to take the drugs . . . (15-year-old
female)
It was necessary that they tell me . . . so that I don’t touch other
people’s things . . . .So that they don’t get AIDS. (8-year-old
male)
I was very happy that they told me this news. To this day I love
my mother because she told me the truth before. If she had told
me when I was an adult . . . ay! When I had grown up . . . that
would not have been good. (15-year-old female)
Discussion
The experiences of disclosure captured here from parents of
children infected with HIV are comparable to those reported
by caregivers in other settings. Caregivers’ decisions to dis-
close are influenced by their concerns around treatment ad-
herence, the eminent onset of sexual activity of adolescents,
and their desire to protect their children and to protect others
from becoming infected.18,31 Caregivers often approach dis-
closure as a process, contemplating disclosure and preparing
for the moment, and providing their infected children with
partial and=or inaccurate information.4,13
In addition, children’s initial reactions to their diagnosis in
this study are similar to those reported in other settings. Other
youth also reported negative reactions upon learning of their
HIV status, ranging from sadness to hurt and worry.7,17,25
From the perspective of the children in this study, disclosure is
a discrete event rather than a process; only one child inter-
viewed described receiving information preparing her to re-
ceive her diagnosis. A few mentioned follow-up discussions
with caregivers or providers, but most did not have subsequent
conversations, although many had questions and concerns.
Youth experiences after being informed of their HIV status,
are not well documented in the literature.8 Here, similar to
other studies,12,32 children had a sense of social isolation and
emotional distress, noted in messages to not touch other
people’s belongings and not share common household items,
and unexpressed questions and concerns resulting perhaps
from messages that worrying will make them sicker, but also
possibly reflecting cultural norms around parent-child com-
munication.
The reports in this study supporting youth being told their
HIV status are also similar to what has been reported else-
where. Blasini and colleagues25 tested an intervention to
support families and youth through the disclosure process;
85% of the youth (ages 9–13 years) afterwards reported dis-
closure as a positive event for them and their families, and
90% supported disclosure in general. However, we cannot
determine whether the intervention itself is the reason for the
positive perspectives. Researchers in Thailand found that
youth who had participated in an intervention to be informed
of their HIV status had more positive attitudes about HIV-
infection and hope for future following the intervention.33
Relief in finally knowing the source of their suffering has also
been reported.7
Access to medication regimens clearly plays a role in dis-
closure to youth in this context. Difficulties adhering to long-
term regimens, whether experienced or anticipated, influence
parents’ decisions to disclose. Youth, in turn, cite being more
conscious of the importance of properly taking medications
following disclosure. The findings here reflect findings seen
in Benin and Thailand,31,34 and point to the need to consider
the complexities of informing children of their HIV status
as programs scaling-up access to AIDS care and treatment
expand.
The experiences of the youth in this study must be under-
stood within the cultural context of Kinshasa. Interventions
should consider how communication takes place within
families in order to inform the design of interventions to assist
families in communicating illness information to children.
Vygotsky35,36 theorized that interpersonal processes gradu-
ally become intrapersonal ones, and that interaction between
individuals structures cognition; interactions between people
therefore shape individuals’ understanding of themselves and
their environment. Within this context, how caregivers and
providers interact with youth and communicate information
about health status—either verbally or nonverbally—could
theoretically have a strong influence on youth’s understand-
ing of their health and well-being. Cultural contexts no doubt
influence parental roles and communication styles with chil-
dren. However, little has been published about what these
roles and styles are, and how culture influences them, par-
ticularly in sub-Saharan Africa. While populations in these
and other similar settings often communicate with children in
a directive, rather than participatory fashion, with few op-
portunities for questioning, discussion, and joint decision-
making made available to children, communication styles will
likely vary based on the age of caregivers, their education
levels, and their exposure to a variety of both traditional and
modern communication styles. A greater emphasis needs to
be placed on understanding the role and function of com-
munication between caregivers and youth in different con-
texts and settings as programs targeting parent–child
communications are developed.
We must be conscious that disclosure may not always be
beneficial. Some studies, including this one, have documented
immediate negative reactions from children upon learning
their HIV status.7,25,34 However, most studies have shown
that in the longer term disclosed children are neither more
distressed nor do they display more behavioral problems than
children who have not been told their HIV status. Only one
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participant in this study expressed any negative things about
knowing her HIV status. Children with inadequate coping
skills or insufficient support systems in place might fare
poorly if inadequately prepared and if follow-up is not pro-
vided. The potential benefits of disclosure must therefore be
weighed against possible negative consequences, before a
decision is made to inform the child of his=her diagnosis, and
adequate support must be put in place for the period fol-
lowing disclosure.
The results have implications for future interventions to
support families who decide to inform HIV-infected children
of their status. Strong messages to children about not wor-
rying need to be moderated by opportunities for children to
express their concerns and gain additional information to
answer their questions about their illness and health. While
ruminating might be detrimental to mental and physical well-
being, suppressing questions or not voicing concerns might
isolate the child and promote poor coping skills. A Brazilian
study found that prolonged silence, poor adult-child com-
munications, and self-discovery resulted in psychosocial
distress, self-stigma and adherence problems among HIV-
positive youth.12 In other studies in clinical settings, health
care providers play a large role in initiating disclosure with
children, sometimes telling parents that it is time that the child
should be told.34,37
In this study’s setting, providers were concerned with
finding the best way to disclose to children, and were there-
fore not intervening with what they saw as the ‘‘natural’’
disclosure process currently taking place until more infor-
mation was made available. It is likely that for this reason, as
well as the comparatively short period of time since ART was
made available in this setting, the prevalence of disclosure
among infected youth is lower than what has been docu-
mented in other similar settings,38,39 The Zimbabwe study
looked at adolescents between the ages of 11–15 years only,39
whereas this study included children ages 5–17 years; age is
associated with disclosure studies.18
Data from the quantitative component of this study, pre-
sented in a separate article, note that caregivers want to be
involved in the decisions and the processes revolving around
disclosure, but that they also want support from health care
providers. A Zimbabwean study examining health provider
and community member perceptions of disclosure of HIV
status to children found that over half of the community
members would want health care workers involved in initi-
ating disclosure and discussions about grief with their chil-
dren.40 In the data presented here, health care providers
played a limited role in the preparation and follow-up to
disclosure. Health service providers can provide more sup-
port to caregivers and children in several ways. First, they can
modify the messages given to youth so that youth feel com-
fortable to ask questions and obtain more information as their
understanding of HIV and their own health evolves. Second,
they can help caregivers address youth concerns by discuss-
ing the questions and concerns brought up by youth and
helping caregivers respond to them. Third, they can engage in
conversations with youth about their health, both before and
after they are told of their HIV status, providing them with
accurate information that will ultimately prepare them to
learn of their diagnosis. Finally, they can provide more psy-
chosocial support, creating opportunities for youth to express
themselves during regular clinic visits and developing sup-
port group sessions especially for youth, in order to help them
adjust to their HIV status. Increased awareness and training of
health care providers to provide appropriate support is
needed.
The study has several limitations. We only interviewed
children whose caregivers knew that they had been told their
HIV status. The experiences of youth who learn of their HIV
status without family knowledge, and the implications this
has for their well-being as well as for health service delivery
for youth, should be explored. We recruited from a facility
that provides medical treatment including access to anti-
retrovirals in a resource-constrained environment. The expe-
riences of families with youth who have been diagnosed but
do not have access to medical care might be quite different
and should be further explored. All of the adults interviewed
were the children’s biological parents, stemming from the fact
that they were the only ones whose children had been told
their HIV status. The caregiver’s relationship to the child
might influence when, where, why, and how a child is in-
formed of their HIV status. Also, caregivers’ own HIV status
might be a strong influence on the disclosure process.
We did not collect clinical information about the children’s
health status. We felt that caregiver’s perceptions of the child’s
health might be more important in understanding disclosure
experiences within families. Also, while we have information
about the age of the child at diagnosis, we do not have in-
formation about the probable mode of transmission to the
child. Mode of HIV acquisition can only rarely be confirmed
in this setting; however, half of the families interviewed had
an HIV-infected parent. Only one of the youth in this study
appears to have been sexually active prior to diagnosis. While
the majority of children in this setting are perinatally infected,
nonparental transmission is a factor, particularly in sub-
Saharan Africa where blood supplies may not be fully secure
and blood transfusions for malaria-induced anemia not un-
common. Furthermore, up until recently, when treatment
became more accessible, children could be sick for many years
before finally being diagnosed with HIV in this setting. Other
literature suggests that HIV-infected caregivers are reluctant
to disclose HIV status to infected children as it means dis-
closing their own status, subjecting them to both guilt as well
as blame for the child’s status.7,41,42 In this study, some of
HIV-positive caregivers chose to tell their children in the
hopes that they could serve as role models to the children in
positive well-being; however, it could be that similar feelings
of guilt or concerns around blame, albeit not mentioned in
interviews, could influence disclosure patterns in this setting.
Despite these limitations, this study is an important step
towards better understanding how youth experience disclo-
sure of their own HIV status. The findings from this study
point to the need for creating comprehensive care and treat-
ment programs for HIV-infected children that address not
only their clinical needs but also their overall well-being.
Further examination of the needs and experiences of children
living with HIV infection and their caregivers will help to
define the roles of health system staff as well as psychosocial
programs throughout the disclosure process.
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